Trifluoroacetic acid → 6-Chloro-2-cyclopropylimidazo[1,2-b]pyridazine-3-carbaldehyde

HRID 2043631ノート

反応式

HRID 2043631 の反応式
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([CH:8]=[C:9]([CH:11]3[CH2:13][CH2:12]3)[N:10]=2)[N:7]=1.FC(F)(F)[C:16](O)=[O:17]>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([C:8]([CH:16]=[O:17])=[C:9]([CH:11]3[CH2:13][CH2:12]3)[N:10]=2)[N:7]=1

参加物

3

反応物 2

HCID 6422Trifluoroacetic acidHCID 536291716-Chloro-2-cyclopropylimidazo[1,2-b]pyridazine

生成物 1

HCID 577430506-Chloro-2-cyclopropylimidazo[1,2-b]pyridazine-3-carbaldehyde収率 45%

実験手順

6-chloro-2-cyclopropylimidazo[1,2-b]pyridazine x105 (1.88 g, 9.71 mmol) and hexamethyltetramine (HMTE, 13.61 g, 97.09 mmol, 10 eq) in trifluoroacetic acid (75 ml) are heated at 60° C. during 6 days. After cooling and solvent evaporation under reduced pressure, the crude product is dissolved in dichloromethane (150 ml). The organic layer is washed with water (150 ml) and the resulting aqueous layer is extracted with dichloromethane (150 ml). The cumulated organic layers are dried over MgSO4, filtered and the solvent is removed by evaporation under reduced pressure. The resulting crude compound is purified by preparative chromatography (benzine/AcOEt:80/20) affording 0.82 g of 6-chloro-2-cyclopropylimidazo[1,2-b]pyridazine-3-carbaldehyde x110.

後処理

  1. temperatureAfter cooling
  2. customsolvent evaporation under reduced pressure
  3. dissolutionthe crude product is dissolved in dichloromethane (150 ml)
  4. washThe organic layer is washed with water (150 ml)
  5. extractionthe resulting aqueous layer is extracted with dichloromethane (150 ml)
  6. dry with materialThe cumulated organic layers are dried over MgSO4
  7. filtrationfiltered
  8. customthe solvent is removed by evaporation under reduced pressure
  9. customThe resulting crude compound is purified by preparative chromatography (benzine/AcOEt:80/20)

出典と根拠

ORDレコード
ord-4cb6441b676a4bd983c0c962e5021ad5
出典データセット
uspto-grants-2013_11
特許番号
US08586623B2

反応ノート

読み込み中…